House mark for pharmaceuticals for the treatment of mitochondrial diseases, disorders, and conditions, cardiovascular diseases, disorders, and conditions, musculoskeletal diseases, disorders, and conditions, neurodegenerative diseases, disorders, and conditions, oncological diseases, disorders, and conditions, metabolic diseases, disorders, and conditions, and diseases, disorders, and conditions related to aging